Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor - PubMed (original) (raw)
Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor
Sara Carbajo-Pescador et al. J Pineal Res. 2011 Nov.
Abstract
Melatonin reduces proliferation in many different cancer cell lines. However, studies on the oncostatic effects of melatonin in hepatocarcinoma are limited. We have previously demonstrated that melatonin administration induces cycle arrest, apoptosis, and changes in the expression of its specific receptors in HepG2 human hepatocarcinoma cells. In this study, we used the receptor antagonist luzindole to assess the contribution of MT1 melatonin membrane receptor to melatonin effects on cell viability, mitogen-activated protein kinase (MAPKs) activation, and cAMP levels. Additionally, effects of MT1 inhibition on mRNA levels of cytosolic quinone reductase type-2 (NQO2) receptor and nuclear retinoic acid-related orphan receptor alpha (RORα) were tested. Melatonin, at 1000 and 2500 μm, significantly reduced cell viability. Pre-incubation with luzindole partially inhibited the effects of melatonin on cell viability. Melatonin at 2500 μm significantly reduced cAMP levels, and this effect was partially blocked by luzindole. Both melatonin concentrations increased the expression of phosphorylated p38, ERK, and JNK. ERK activation was completely abolished in the presence of luzindole. NQO2 but not RORα mRNA level significantly increased in luzindole-treated cells. Results obtained provide evidence that the melatonin effects on cell viability and proliferation in HepG2 cells are partially mediated through the MT1 membrane receptor, which seems to be related also with melatonin modulation of cAMP and ERK activation. This study also highlights a possible interplay between MT1 and NQO2 melatonin receptors in liver cancer cells.
© 2011 John Wiley & Sons A/S.
Similar articles
- Inverse agonist exposure enhances ligand binding and G protein activation of the human MT1 melatonin receptor, but leads to receptor down-regulation.
Kokkola T, Vaittinen M, Laitinen JT. Kokkola T, et al. J Pineal Res. 2007 Oct;43(3):255-62. doi: 10.1111/j.1600-079X.2007.00470.x. J Pineal Res. 2007. PMID: 17803522 - Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation.
Jawed S, Kim B, Ottenhof T, Brown GM, Werstiuk ES, Niles LP. Jawed S, et al. Eur J Pharmacol. 2007 Mar 29;560(1):17-22. doi: 10.1016/j.ejphar.2007.01.022. Epub 2007 Jan 23. Eur J Pharmacol. 2007. PMID: 17303109 - MT1 melatonin receptor internalization underlies melatonin-induced morphologic changes in Chinese hamster ovary cells and these processes are dependent on Gi proteins, MEK 1/2 and microtubule modulation.
Bondi CD, McKeon RM, Bennett JM, Ignatius PF, Brydon L, Jockers R, Melan MA, Witt-Enderby PA. Bondi CD, et al. J Pineal Res. 2008 Apr;44(3):288-98. doi: 10.1111/j.1600-079X.2007.00525.x. J Pineal Res. 2008. PMID: 18339124 - [MT1 melatonin receptors and their role in the oncostatic action of melatonin].
Danielczyk K, Dziegiel P. Danielczyk K, et al. Postepy Hig Med Dosw (Online). 2009 Sep 15;63:425-34. Postepy Hig Med Dosw (Online). 2009. PMID: 19837985 Review. Polish. - Age-related decline in melatonin and its MT1 receptor are associated with decreased sensitivity to melatonin and enhanced mammary tumor growth.
Hill SM, Cheng C, Yuan L, Mao L, Jockers R, Dauchy B, Blask DE. Hill SM, et al. Curr Aging Sci. 2013 Feb;6(1):125-33. doi: 10.2174/1874609811306010016. Curr Aging Sci. 2013. PMID: 23895529 Review.
Cited by
- Effects of combination of melatonin and laser irradiation on ovarian cancer cells and endothelial lineage viability.
Akbarzadeh M, Nouri M, Banekohal MV, Cheraghi O, Tajalli H, Movassaghpour A, Soltani S, Cheraghi H, Feizy N, Montazersaheb S, Rahbarghazi R, Samadi N. Akbarzadeh M, et al. Lasers Med Sci. 2016 Nov;31(8):1565-1572. doi: 10.1007/s10103-016-2016-6. Epub 2016 Jun 30. Lasers Med Sci. 2016. PMID: 27365110 - Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy.
Prieto-Domínguez N, Ordóñez R, Fernández A, Méndez-Blanco C, Baulies A, Garcia-Ruiz C, Fernández-Checa JC, Mauriz JL, González-Gallego J. Prieto-Domínguez N, et al. J Pineal Res. 2016 Oct;61(3):396-407. doi: 10.1111/jpi.12358. Epub 2016 Aug 19. J Pineal Res. 2016. PMID: 27484637 Free PMC article. - Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
Lo Sardo F, Muti P, Blandino G, Strano S. Lo Sardo F, et al. Int J Mol Sci. 2017 Sep 6;18(9):1913. doi: 10.3390/ijms18091913. Int J Mol Sci. 2017. PMID: 28878191 Free PMC article. - Real-Time Determination of Intracellular cAMP Reveals Functional Coupling of Gs Protein to the Melatonin MT1 Receptor.
Tse LH, Cheung ST, Lee S, Wong YH. Tse LH, et al. Int J Mol Sci. 2024 Mar 2;25(5):2919. doi: 10.3390/ijms25052919. Int J Mol Sci. 2024. PMID: 38474167 Free PMC article. - Melatonin for the prevention and treatment of cancer.
Li Y, Li S, Zhou Y, Meng X, Zhang JJ, Xu DP, Li HB. Li Y, et al. Oncotarget. 2017 Jun 13;8(24):39896-39921. doi: 10.18632/oncotarget.16379. Oncotarget. 2017. PMID: 28415828 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous